NCT01556997 - Perindopril Amlodipine for the Treatment of Hypertension | Biotech Hunter

Enrollment

837

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Essential Hypertension

Interventions

DRUG

XOMA 985

PERa/AMLb capsule taken once daily by mouth for six weeks

DRUG

Amlodipine Besylate

AMLb capsule taken once daily by mouth for six weeks

DRUG

Perindopril Erbumine

PERe capsule taken once daily by mouth for six weeks

Trial Locations (48)

Unknown

Huntsville

Muscle Shoals

Glendale

Greenbrae

Los Angeles

Santa Ana

Denver

DeLand

Fort Lauderdale

Miami

Palm Harbor

Port Orange

Marietta

Gurnee

Indianapolis

Wichita

Louisville

Metairie

Auburn

Baltimore

Olive Branch

Butte

Berlin

Greensboro

Hickory

Raleigh

Winston-Salem

Cincinnati

Columbus

Kettering

Lyndhurst

Marion

Oklahoma City

Tulsa

Eugene

Mt. Pleasant

Simpsonville

Bristol

Austin

Corpus Christi

Dallas

Fort Worth

Houston

Katy

San Antonio

Salt Lake City

Norfolk

Richmond

All Listed Sponsors

lead

Symplmed Pharmaceuticals LLC

INDUSTRY